Ajanta Pharma – Filesadmin.co

Ajanta Pharma Q1 results: PAT up 18% to Rs 246 cr on robust sales

The company said its India sales grew 10 per cent year-on-year to Rs 353 crore in the first quarter. |

Ajanta Pharma has continued its tradition of rewarding shareholders. The company announced a new buyback programme with a record date

Domestic benchmark indices open higher on Friday’s trade. BSE Sensex trader at 75,066.38, higher by 455.27 pts or 0.61 per cent as

Consolidated revenue from operations was at Rs 1,028.44 crore as against Rs 938.10 crore in the year-ago period, it added

India’s market regulator, seeking to reduce risks for retail investors, will propose linking the amount of equity derivatives they may

Ajanta Pharma Ltd.’s share price rose after the company reported a 19 per cent increase in profit after tax for

As part of its growth plans, Ajanta Pharma is looking forward to strengthening its presence across specific geographies with high